These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1176582)

  • 1. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.
    Meikle AW; Weed JA; Tyler FH
    J Clin Endocrinol Metab; 1975 Oct; 41(4):717-21. PubMed ID: 1176582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
    Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of radioimmunoassays for prednisone and prednisolone. Application to studies of hepatic metabolism of prednisone.
    Schalm SW; Summerskill WH; Go VL
    Mayo Clin Proc; 1976 Dec; 51(12):761-6. PubMed ID: 994553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.
    Unadkat JD; Rowland M
    Drug Metab Dispos; 1985; 13(4):503-9. PubMed ID: 2863117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone clearance at steady state in man.
    Legler UF; Frey FJ; Benet LZ
    J Clin Endocrinol Metab; 1982 Oct; 55(4):762-7. PubMed ID: 7107818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies comparing the metabolic clearance rate of 11 beta,17,21-trihydroxypregn-1,4-diene-3,20-dione (prednisolone) after oral 17,21-dihydroxypregn-1,4-diene-3,11,20-trione and intravenous prednisolone.
    Hsueh WA; Paz-Guevara A; Bledsoe T
    J Clin Endocrinol Metab; 1979 May; 48(5):748-52. PubMed ID: 429520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of prednisone and prednisolone by plasma exchange.
    Stigelman WH; Henry DH; Talbert RL; Townsend RJ
    Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative serum prednisone and prednisolone concentrations following prednisone or prednisolone administration to beagle dogs.
    Colburn WA; Sibley CR; Buller RH
    J Pharm Sci; 1976 Jul; 65(7):997-1001. PubMed ID: 957135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
    Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
    Gut; 1980 Jan; 21(1):52-6. PubMed ID: 7364321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics.
    Rose JQ; Yurchak AM; Meikle AW; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):1-14. PubMed ID: 7229914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of liver function on the metabolism of prednisone and prednisolone in humans.
    Renner E; Horber FF; Jost G; Frey BM; Frey FJ
    Gastroenterology; 1986 Apr; 90(4):819-28. PubMed ID: 3512355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
    Frey BM; Walker C; Frey FJ; de Weck AL
    J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and metabolism of prednisone in mice, dogs, and monkeys.
    El Dareer SM; Struck RF; White VM; Mellett LB; Hill DL
    Cancer Treat Rep; 1977 Oct; 61(7):1279-89. PubMed ID: 412589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
    Center SA; Randolph JF; Warner KL; Simpson KW; Rishniw M
    Res Vet Sci; 2013 Aug; 95(1):225-30. PubMed ID: 23473553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone.
    Sirgo MA; Rocci ML; Ferguson RK; Eshelman FN; Vlasses PH
    Clin Pharmacol Ther; 1985 May; 37(5):534-8. PubMed ID: 3987177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyroid dysfunction on prednisolone and prednisone interconversion and disposition in the rat.
    Murata R; Haughey DB; Jusko WJ
    Drug Metab Dispos; 1990; 18(4):403-8. PubMed ID: 1976060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of prednisolone and endogenous cortisol suppression in the elderly.
    Stuck AE; Frey BM; Frey FJ
    Clin Pharmacol Ther; 1988 Apr; 43(4):354-62. PubMed ID: 3356080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo availability of commercial prednisone tablets.
    Sullivan TJ; Sakmar E; Albert KS; Blair DC; Wagner JG
    J Pharm Sci; 1975 Oct; 64(10):1723-5. PubMed ID: 1102660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.
    Frey BM; Seeberger M; Frey FJ
    Transplantation; 1985 Mar; 39(3):270-4. PubMed ID: 3883592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver disease.
    Uribe M; Summerskill WH; Go VL
    Clin Pharmacokinet; 1982; 7(5):452-9. PubMed ID: 7140120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.